Heres what business owners and HR leaders should know
Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression
adults is using or considering GLP-1s The National Academy of Sports Medicine (NASM) has launched a new course, Understanding Weight Loss Medications for fitness and wellness professionals to better serve clients on weight loss medications
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that slows stomach emptying and reduces appetite signals in the brain, helping patients achieve meaningful weight loss